Literature DB >> 11444589

Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype.

T A Castleberry1, B Lu, S L Smock, T A Owen.   

Abstract

Prostaglandin E2 (PGE2) is an important mediator of diverse biologic functions in many tissues and binds with high affinity to four cell surface, seven-transmembrane domain, G protein-coupled receptors (EP1-EP4). The EP4 receptor subtype has a long intracellular carboxy-terminal region and is functionally coupled to adenylate cyclase, resulting in elevated intracellular cyclic adenosine 5' monophosphate (cAMP) levels upon activation. To further study EP4 receptor subtype function, a canine kidney cDNA library was screened and three clones were isolated and sequenced. The longest clone was 3,103 bp and contained a single open reading frame of 1,476 bp, potentially encoding a protein of 492 amino acids with a predicted molecular weight of 53.4 kDa. Sequence analysis of this open reading frame reveals 89% identity to the human EP4 protein coding region at the nucleotide level and 90% identity when the putative canine and human protein sequences are compared. Northern blot analysis showed relatively high levels of canine EP4 expression in heart, lung and kidney, while Southern blot analysis of canine genomic DNA suggests the presence of a single copy gene. Following transfection of canine EP4 into CHO-KI cells, Scatchard analysis revealed a dissociation constant of 24 nM for PGE, while competition binding studies using 3H-PGE2 as ligand demonstrated specific displacement by PGE2 prostaglandin E, (PGE1), and prostaglandin A3 (PGA3). Treatment with PGE2 also resulted in increased levels of cAMP in transfected, but not in parental, CHO-KI cells. In contrast, butaprost, an EP2 selective ligand, and sulprostone, an EP1/EP3 selective ligand, did not bind to this receptor at the maximal concentration used (320 nM). To further investigate secondary signaling, the canine EP4 cDNA was truncated to produce an 1,117 bp fragment encoding a 356 amino acid protein lacking the intracellular carboxy-terminus. When transfected, this truncated cDNA produced a protein with a dissociation constant of 11 nM for PGE2 and a binding and cAMP accumulation profile similar to that of the full-length protein. Both full-length and truncated canine EP4 underwent short term PGE2-induced desensitization as shown by a lack of continuing cAMP accumulation after the initial PGE2 stimulation, suggesting no involvement of the C-terminal intracellular tail. This result is in contrast to that reported for the human EP4 receptor, where residues within the C-terminal intracellular tail were shown to mediate short term, ligand induced desensitization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444589     DOI: 10.1016/s0090-6980(01)00129-0

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  9 in total

1.  Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.

Authors:  Margaret L Musser; Austin K Viall; Rachel L Phillips; Jesse M Hostetter; Chad M Johannes
Journal:  Can J Vet Res       Date:  2021-01       Impact factor: 1.310

2.  Regulation of human penile smooth muscle tone by prostanoid receptors.

Authors:  Javier Angulo; Pedro Cuevas; Jose M La Fuente; Jose M Pomerol; Eduardo Ruiz-Castañé; Ana Puigvert; Sonia Gabancho; Argentina Fernández; Peter Ney; Iñigo Sáenz De Tejada
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

3.  Polarized Th1 and Th2 cells are less responsive to negative feedback by receptors coupled to the AC/cAMP system compared to freshly isolated T cells.

Authors:  Irene H Heijink; Edo Vellenga; Peter Borger; Dirkje S Postma; Jan G R de Monchy; Henk F Kauffman
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

4.  An EP2 receptor-selective prostaglandin E2 agonist induces bone healing.

Authors:  V M Paralkar; F Borovecki; H Z Ke; K O Cameron; B Lefker; W A Grasser; T A Owen; M Li; P DaSilva-Jardine; M Zhou; R L Dunn; F Dumont; R Korsmeyer; P Krasney; T A Brown; D Plowchalk; S Vukicevic; D D Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-14       Impact factor: 11.205

5.  Molecular cloning and functional characterization of the canine parathyroid hormone/parathyroid hormone related peptide receptor (PTH1).

Authors:  S L Smock; G A Vogt; T A Castleberry; B Lu; T A Owen
Journal:  Mol Biol Rep       Date:  2001       Impact factor: 2.316

Review 6.  Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation.

Authors:  Kristin Kirkby Shaw; Lesley C Rausch-Derra; Linda Rhodes
Journal:  Vet Med Sci       Date:  2015-12-21

Review 7.  Mapping PTGERs to the Ovulatory Follicle: Regional Responses to the Ovulatory PGE2 Signal.

Authors:  Soon Ok Kim; Diane M Duffy
Journal:  Biol Reprod       Date:  2016-06-15       Impact factor: 4.285

8.  Gene expression of prostaglandin EP4 receptor in three canine carcinomas.

Authors:  Margaret L Musser; Austin K Viall; Rachel L Phillips; Jesse M Hostetter; Chad M Johannes
Journal:  BMC Vet Res       Date:  2020-06-22       Impact factor: 2.741

Review 9.  Grapiprant: A snapshot of the current knowledge.

Authors:  Irene Sartini; Mario Giorgi
Journal:  J Vet Pharmacol Ther       Date:  2021-05-31       Impact factor: 1.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.